Menu
Not yet recruiting NCT07740668

Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After Stroke

No phase Interventional Stroke Overactive Bladder (OAB) Tibial Nerve

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: posterior tibial nerve stimulation, PTNS.
Who it may be relevant to
Registry conditions: Stroke, Overactive Bladder (OAB), Tibial Nerve. Basic parameters: 40 years — 70 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke. Primary Hypothesis: PTNS therapy will significantly improve OAB symptoms in post-stroke patients compared to standard care/sham stimulation. Primary Outcome Measure: Change from baseline in Overactive Bladder Symptom Score (OABSS) and/or frequency of urgency episodes as assessed after 12 weeks of treatment."

Detailed description

controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke.

Interventions

  • Device posterior tibial nerve stimulation, PTNS
    posterior tibial nerve stimulation, PTNS

Primary outcome measures

  • Change in daily frequency of urgency episodes [Time frame: Baseline and at 12 weeks.]
Secondary outcome measures (1)
  • Change in micturition frequency [Time frame: Baseline and at 12 weeks.]

Eligibility criteria

Inclusion criteria

  • Female
  • Age 40 to 70 years
  • History of ischemic or hemorrhagic stroke at least 6 months before enrollment
  • Presence of overactive bladder symptoms
  • Ability to provide written informed consent

Exclusion criteria

  • Age outside the study range
  • Pregnancy or breastfeeding
  • Active urinary tract infection
  • Neurogenic conditions other than stroke affecting bladder function
  • Inability to comply with study procedures
  • Refusal or inability to provide informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Kutahya Health Sciences University — Kütahya

Identifiers

NCT: NCT07740668 · AAM-PTNS-2025-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗